Research Articles
The Invisible Tug-of-War in Our Cells: How Cellular "Rivals" Team Up to Drive Cancer
Discover how KRAS and TGF-β pathways collaborate through SIAH2 to drive cancer progression and metastasis in this comprehensive scientific analysis.
Cracking Cancer's Code: A New Map to Find Its Secret Weaknesses
Discover how Reverse Phase Protein Array (RPPA) technology is revolutionizing cancer treatment by identifying precise molecular targets for personalized therapies.
Disarming Cancer's Repair Crew: A New Tactic to Boost Radiation Therapy
Discover how TAK-243, a UAE inhibitor, disrupts DNA damage repair in cancer cells and enhances radiation therapy effectiveness.
A Tiny Window into the Tumor: Poking Cancer to See How it Fights Back
Discover how the CIVO platform and TAK-981 are revolutionizing cancer drug development by providing real-time insights into tumor immune responses.
Harnessing Nature's Blueprint: The Hunt for a Cancer-Fighting Molecule
Exploring how computational drug design identifies promising compounds from soursop to combat cancer by targeting the PirH2 protein.
Molecular Spies: Engineering Unbreakable Peptides to Sniff Out Cancer
Discover how scientists are engineering protease-resistant β-hairpin peptides to detect cancer activity with unprecedented precision.
Disarming Cancer's Inner Mountaineer: How Blocking a Single Protein Could Halt Tumors
Discover how targeting the UCHL1 protein disrupts cancer's ability to thrive in low-oxygen environments and prevents tumor growth and metastasis.
The Cellular Double Agent: How Flipping a Cancer "Shield" into a "Kill Signal" Offers New Hope
Discover how scientists are turning the SUMO1 cancer protein shield into a kill signal using PROTAC degraders, offering new hope for cancer treatment.
Disarming Cancer's Master Switch: The Quest to Tame Rogue Wnt Signaling
How a clever new strategy of molecular jamming is taking aim at a notoriously undruggable pathway in cancer through novel peptides targeting the β-catenin/TBL1 complex.
A Wolf in Sheep's Clothing: Can a "Growth" Drug Starve Cancer?
Scientists are investigating a surprising new weapon in the fight against cancer using Ibutamoren, a drug that exploits the body's anti-cancer systems.